Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Briacell Therapeutics Corp
(NQ:
BCTX
)
0.7600
-0.1611 (-17.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,859,433
Open
0.9300
Bid (Size)
0.7399 (7)
Ask (Size)
0.7600 (16)
Prev. Close
0.9211
Today's Range
0.7200 - 0.9316
52wk Range
0.8500 - 7.590
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024
June 14, 2024
BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 28, 2024
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!
Via
InvestorPlace
Performance
YTD
-85.77%
-85.77%
1 Month
-48.65%
-48.65%
3 Month
-64.81%
-64.81%
6 Month
-82.88%
-82.88%
1 Year
-88.34%
-88.34%
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 21, 2024
Via
InvestorPlace
BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024
March 19, 2024
Via
InvestorPlace
BriaCell: An Emerging Immuno - Oncology Company
August 14, 2023
Via
Talk Markets
Exposures
Product Safety
New Treatments May Help Those With Advanced Breast Cancer Live Longer
April 17, 2023
Via
StatePoint Media
Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer
February 08, 2023
Via
Talk Markets
Get Rich Quick With These 3 Penny Stocks to Buy Now
February 12, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
December 20, 2023
Via
Benzinga
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
May 31, 2023
Via
NewMediaWire
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
May 30, 2023
Via
TheNewswire.com
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
May 30, 2023
Via
NewMediaWire
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
March 24, 2023
Via
FinancialNewsMedia
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
Via
Talk Markets
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
January 18, 2023
Via
Talk Markets
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Via
News Direct
Topics
Death
Exposures
Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Via
TheNewswire.com
Topics
Death
Exposures
Death
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 13, 2022
Via
Benzinga
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 02, 2022
Via
TheNewswire.com
Topics
Stocks
Exposures
Product Safety
US Equities
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 02, 2022
Via
News Direct
Exposures
Product Safety
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 01, 2022
Via
Benzinga
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
November 30, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Via
Benzinga
Why Is BriaCell (BCTX) Stock Moving Today?
April 13, 2022
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
